Laboratorio Reig Jofre S.A (MC:RJF) — Market Cap & Net Worth
Market Cap & Net Worth: Laboratorio Reig Jofre S.A (RJF)
Laboratorio Reig Jofre S.A (MC:RJF) has a market capitalization of $221.39 Million (€189.37 Million) as of May 7, 2026. Listed on the MC stock exchange, this Spain-based company holds position #16196 globally and #105 in its home market, demonstrating a 4.09% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Laboratorio Reig Jofre S.A's stock price €2.80 by its total outstanding shares 81394434 (81.39 Million). Analyse RJF cash generation efficiency to see how efficiently the company converts income to cash.
Laboratorio Reig Jofre S.A Market Cap History: 2015 to 2026
Laboratorio Reig Jofre S.A's market capitalization history from 2015 to 2026. Data shows change from $299.87 Million to $266.44 Million (-2.39% CAGR).
Laboratorio Reig Jofre S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Laboratorio Reig Jofre S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.70x
Laboratorio Reig Jofre S.A's market cap is 0.70 times its annual revenue
Latest Price to Earnings (P/E) Ratio
22.82x
Laboratorio Reig Jofre S.A's market cap is 22.82 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $299.87 Million | $156.91 Million | $8.75 Million | 1.91x | 34.27x |
| 2016 | $271.11 Million | $161.13 Million | $7.68 Million | 1.68x | 35.32x |
| 2017 | $205.74 Million | $167.98 Million | $8.83 Million | 1.22x | 23.30x |
| 2018 | $203.26 Million | $180.47 Million | $9.27 Million | 1.13x | 21.94x |
| 2019 | $227.92 Million | $200.21 Million | $4.94 Million | 1.14x | 46.12x |
| 2020 | $399.91 Million | $230.08 Million | $5.67 Million | 1.74x | 70.51x |
| 2021 | $299.06 Million | $236.23 Million | $5.09 Million | 1.27x | 58.73x |
| 2022 | $203.24 Million | $271.15 Million | $8.11 Million | 0.75x | 25.07x |
| 2023 | $211.59 Million | $316.09 Million | $9.41 Million | 0.67x | 22.49x |
| 2024 | $236.95 Million | $338.89 Million | $10.38 Million | 0.70x | 22.82x |
Competitor Companies of RJF by Market Capitalization
Companies near Laboratorio Reig Jofre S.A in the global market cap rankings as of May 7, 2026.
Key companies related to Laboratorio Reig Jofre S.A by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #501 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #530 globally with a market cap of $50.06 Billion USD ( CN¥342.11 Billion CNY).
- Zoetis Inc (NYSE:ZTS): Ranked #541 globally with a market cap of $49.01 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #574 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #501 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.06 Billion | CN¥53.63 |
| #541 | Zoetis Inc | NYSE:ZTS | $49.01 Billion | $111.22 |
| #574 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $43.83 |
Laboratorio Reig Jofre S.A Historical Marketcap From 2015 to 2026
Between 2015 and today, Laboratorio Reig Jofre S.A's market cap moved from $299.87 Million to $ 266.44 Million, with a yearly change of -2.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €266.44 Million | +8.95% |
| 2025 | €244.56 Million | +3.21% |
| 2024 | €236.95 Million | +11.99% |
| 2023 | €211.59 Million | +4.11% |
| 2022 | €203.24 Million | -32.04% |
| 2021 | €299.06 Million | -25.22% |
| 2020 | €399.91 Million | +75.46% |
| 2019 | €227.92 Million | +12.13% |
| 2018 | €203.26 Million | -1.21% |
| 2017 | €205.74 Million | -24.11% |
| 2016 | €271.11 Million | -9.59% |
| 2015 | €299.87 Million | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Laboratorio Reig Jofre S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $221.39 Million USD |
| MoneyControl | $221.39 Million USD |
| MarketWatch | $221.39 Million USD |
| marketcap.company | $221.39 Million USD |
| Reuters | $221.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Laboratorio Reig Jofre S.A
Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables … Read more